Humanoid Robot Market to Reach $2B by 2032; J&J's Monarch Platform Shows High Success in Robotic Bronchoscopy
Key Takeaways
- Humanoid robot market: 40,000 units, $2 billion revenue by 2032 (Interact Analysis report).
- J&J's Monarch platform: 98.7% reach, 83.2% diagnostic yield in lung nodule study.
- Free webinar on June 3, 2025: Gearing, drives, controllers for picking and palletizing.
Top Stories
Humanoid robot market: 40,000 units, $2B revenue by 2032
A report by Interact Analysis, published on 2025-06-02, forecasts the humanoid robot market to reach over 40,000 units by 2032, generating $2 billion in revenue. Separately, on 2025-06-02, Schaeffler Group showcased components for humanoid robots at the Hannover Messe trade show in Germany.
J&J Monarch platform: 98% reach, 83.2% diagnostic yield
Johnson & Johnson MedTech announced on 2025-06-02 the results from the TARGET study of its Monarch platform for robotic bronchoscopy procedures. The study, involving 679 patients across 21 global sites, showed clinicians could reach small lung nodules in 98.7% of cases with a diagnostic yield of 83.2%, with a safety profile comparable to non-robotic bronchoscopy.
Free webinar: Gearing, drives, controllers on June 3, 2025
On June 3, 2025, at 2:00 p.m. EDT, a free webinar about gearing, drives, and controllers for applications such as piece picking and palletizing will be held. The webinar is sponsored by GAM and hosted by Eugene Demaitre of WTWH Media; the report was published on 2025-06-02.